Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serena Bugatti

Showing results (21-30 of 92) with videos related to

Pageof 10
Sort By:
Arthritis and Rheumatism|November 1, 2005
Involvement of subchondral bone marrow in rheumatoid arthritis: lymphoid neogenesis and in situ relationship to subchondral bone marrow osteoclast recruitmentSerena Bugatti, Roberto Caporali, Antonio Manzo, et al.
Immunology Letters|June 16, 2012
Role of lymphoid chemokines in the development of functional ectopic lymphoid structures in rheumatic autoimmune diseasesElisa Corsiero, Michele Bombardieri, Antonio Manzo, et al.
Journal of Clinical Medicine|July 2, 2021
In Patients with Early Peripheral Psoriatic Arthritis Baseline C-Reactive Protein, Pain and Ultrasound-Detected Synovitis Predict Subsequent Treatment with ts/bDMARDs. A Retrospective AnalysisGarifallia Sakellariou, Silvana Quaglini, Serena Bugatti, et al.
Autoimmunity Reviews|November 1, 2011
Early treatment in early undifferentiated arthritisIgnazio Olivieri, Piercarlo Sarzi-Puttini, Serena Bugatti, et al.
Annals of the New York Academy of Sciences|April 20, 2010
Early disease control by low-dose prednisone comedication may affect the quality of remission in patients with early rheumatoid arthritisMonica Todoerti, Carlo Alberto Scirè, Nicola Boffini, et al.
Autoimmunity Reviews|June 27, 2013
Long-term safety of abatacept in patients with rheumatoid arthritisFabiola Atzeni, Piercarlo Sarzi-Puttini, Alessandra Mutti, et al.
Arthritis Research & Therapy|May 15, 2004
Autoantibody profile in rheumatoid arthritis during long-term infliximab treatmentFrancesca Bobbio-Pallavicini, Claudia Alpini, Roberto Caporali, et al.
Therapeutic Advances in Musculoskeletal Disease|October 9, 2023
Impact of csDMARDs adherence on clinical remission in patients with new-onset inflammatory arthritis: a prospective cohort study from the ELECTRA databaseAnna Zanetti, Antonella Zambon, Carlo A Scirè, et al.
Therapeutic Advances in Musculoskeletal Disease|June 7, 2021
Limiting factors to Boolean remission differ between autoantibody-positive and -negative patients in early rheumatoid arthritisSerena Bugatti, Ludovico De Stefano, Antonio Manzo, et al.
Autoimmunity Reviews|June 29, 2013
WITHDRAWN: Abatacept as a first-line biological therapyRoberto Caporali, Serena Bugatti, Lorenzo Cavagna, et al.
Pageof 10

Showing results (21-30 of 92) with videos related to

Sort By:
Pageof 10
Arthritis and Rheumatism|November 1, 2005
Involvement of subchondral bone marrow in rheumatoid arthritis: lymphoid neogenesis and in situ relationship to subchondral bone marrow osteoclast recruitmentSerena Bugatti, Roberto Caporali, Antonio Manzo, et al.
Immunology Letters|June 16, 2012
Role of lymphoid chemokines in the development of functional ectopic lymphoid structures in rheumatic autoimmune diseasesElisa Corsiero, Michele Bombardieri, Antonio Manzo, et al.
Journal of Clinical Medicine|July 2, 2021
In Patients with Early Peripheral Psoriatic Arthritis Baseline C-Reactive Protein, Pain and Ultrasound-Detected Synovitis Predict Subsequent Treatment with ts/bDMARDs. A Retrospective AnalysisGarifallia Sakellariou, Silvana Quaglini, Serena Bugatti, et al.
Autoimmunity Reviews|November 1, 2011
Early treatment in early undifferentiated arthritisIgnazio Olivieri, Piercarlo Sarzi-Puttini, Serena Bugatti, et al.
Annals of the New York Academy of Sciences|April 20, 2010
Early disease control by low-dose prednisone comedication may affect the quality of remission in patients with early rheumatoid arthritisMonica Todoerti, Carlo Alberto Scirè, Nicola Boffini, et al.
Autoimmunity Reviews|June 27, 2013
Long-term safety of abatacept in patients with rheumatoid arthritisFabiola Atzeni, Piercarlo Sarzi-Puttini, Alessandra Mutti, et al.
Arthritis Research & Therapy|May 15, 2004
Autoantibody profile in rheumatoid arthritis during long-term infliximab treatmentFrancesca Bobbio-Pallavicini, Claudia Alpini, Roberto Caporali, et al.
Therapeutic Advances in Musculoskeletal Disease|October 9, 2023
Impact of csDMARDs adherence on clinical remission in patients with new-onset inflammatory arthritis: a prospective cohort study from the ELECTRA databaseAnna Zanetti, Antonella Zambon, Carlo A Scirè, et al.
Therapeutic Advances in Musculoskeletal Disease|June 7, 2021
Limiting factors to Boolean remission differ between autoantibody-positive and -negative patients in early rheumatoid arthritisSerena Bugatti, Ludovico De Stefano, Antonio Manzo, et al.
Autoimmunity Reviews|June 29, 2013
WITHDRAWN: Abatacept as a first-line biological therapyRoberto Caporali, Serena Bugatti, Lorenzo Cavagna, et al.
Pageof 10